Cargando…
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853475/ https://www.ncbi.nlm.nih.gov/pubmed/35176007 http://dx.doi.org/10.15585/mmwr.mm7107e2 |
_version_ | 1784653236367523840 |
---|---|
author | Ferdinands, Jill M. Rao, Suchitra Dixon, Brian E. Mitchell, Patrick K. DeSilva, Malini B. Irving, Stephanie A. Lewis, Ned Natarajan, Karthik Stenehjem, Edward Grannis, Shaun J. Han, Jungmi McEvoy, Charlene Ong, Toan C. Naleway, Allison L. Reese, Sarah E. Embi, Peter J. Dascomb, Kristin Klein, Nicola P. Griggs, Eric P. Konatham, Deepika Kharbanda, Anupam B. Yang, Duck-Hye Fadel, William F. Grisel, Nancy Goddard, Kristin Patel, Palak Liao, I-Chia Birch, Rebecca Valvi, Nimish R. Reynolds, Sue Arndorfer, Julie Zerbo, Ousseny Dickerson, Monica Murthy, Kempapura Williams, Jeremiah Bozio, Catherine H. Blanton, Lenee Verani, Jennifer R. Schrag, Stephanie J. Dalton, Alexandra F. Wondimu, Mehiret H. Link-Gelles, Ruth Azziz-Baumgartner, Eduardo Barron, Michelle A. Gaglani, Manjusha Thompson, Mark G. Fireman, Bruce |
author_facet | Ferdinands, Jill M. Rao, Suchitra Dixon, Brian E. Mitchell, Patrick K. DeSilva, Malini B. Irving, Stephanie A. Lewis, Ned Natarajan, Karthik Stenehjem, Edward Grannis, Shaun J. Han, Jungmi McEvoy, Charlene Ong, Toan C. Naleway, Allison L. Reese, Sarah E. Embi, Peter J. Dascomb, Kristin Klein, Nicola P. Griggs, Eric P. Konatham, Deepika Kharbanda, Anupam B. Yang, Duck-Hye Fadel, William F. Grisel, Nancy Goddard, Kristin Patel, Palak Liao, I-Chia Birch, Rebecca Valvi, Nimish R. Reynolds, Sue Arndorfer, Julie Zerbo, Ousseny Dickerson, Monica Murthy, Kempapura Williams, Jeremiah Bozio, Catherine H. Blanton, Lenee Verani, Jennifer R. Schrag, Stephanie J. Dalton, Alexandra F. Wondimu, Mehiret H. Link-Gelles, Ruth Azziz-Baumgartner, Eduardo Barron, Michelle A. Gaglani, Manjusha Thompson, Mark G. Fireman, Bruce |
author_sort | Ferdinands, Jill M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8853475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-88534752022-03-01 Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 Ferdinands, Jill M. Rao, Suchitra Dixon, Brian E. Mitchell, Patrick K. DeSilva, Malini B. Irving, Stephanie A. Lewis, Ned Natarajan, Karthik Stenehjem, Edward Grannis, Shaun J. Han, Jungmi McEvoy, Charlene Ong, Toan C. Naleway, Allison L. Reese, Sarah E. Embi, Peter J. Dascomb, Kristin Klein, Nicola P. Griggs, Eric P. Konatham, Deepika Kharbanda, Anupam B. Yang, Duck-Hye Fadel, William F. Grisel, Nancy Goddard, Kristin Patel, Palak Liao, I-Chia Birch, Rebecca Valvi, Nimish R. Reynolds, Sue Arndorfer, Julie Zerbo, Ousseny Dickerson, Monica Murthy, Kempapura Williams, Jeremiah Bozio, Catherine H. Blanton, Lenee Verani, Jennifer R. Schrag, Stephanie J. Dalton, Alexandra F. Wondimu, Mehiret H. Link-Gelles, Ruth Azziz-Baumgartner, Eduardo Barron, Michelle A. Gaglani, Manjusha Thompson, Mark G. Fireman, Bruce MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-02-18 /pmc/articles/PMC8853475/ /pubmed/35176007 http://dx.doi.org/10.15585/mmwr.mm7107e2 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
spellingShingle | Full Report Ferdinands, Jill M. Rao, Suchitra Dixon, Brian E. Mitchell, Patrick K. DeSilva, Malini B. Irving, Stephanie A. Lewis, Ned Natarajan, Karthik Stenehjem, Edward Grannis, Shaun J. Han, Jungmi McEvoy, Charlene Ong, Toan C. Naleway, Allison L. Reese, Sarah E. Embi, Peter J. Dascomb, Kristin Klein, Nicola P. Griggs, Eric P. Konatham, Deepika Kharbanda, Anupam B. Yang, Duck-Hye Fadel, William F. Grisel, Nancy Goddard, Kristin Patel, Palak Liao, I-Chia Birch, Rebecca Valvi, Nimish R. Reynolds, Sue Arndorfer, Julie Zerbo, Ousseny Dickerson, Monica Murthy, Kempapura Williams, Jeremiah Bozio, Catherine H. Blanton, Lenee Verani, Jennifer R. Schrag, Stephanie J. Dalton, Alexandra F. Wondimu, Mehiret H. Link-Gelles, Ruth Azziz-Baumgartner, Eduardo Barron, Michelle A. Gaglani, Manjusha Thompson, Mark G. Fireman, Bruce Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 |
title | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 |
title_full | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 |
title_fullStr | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 |
title_full_unstemmed | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 |
title_short | Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 |
title_sort | waning 2-dose and 3-dose effectiveness of mrna vaccines against covid-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance — vision network, 10 states, august 2021–january 2022 |
topic | Full Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853475/ https://www.ncbi.nlm.nih.gov/pubmed/35176007 http://dx.doi.org/10.15585/mmwr.mm7107e2 |
work_keys_str_mv | AT ferdinandsjillm waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT raosuchitra waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT dixonbriane waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT mitchellpatrickk waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT desilvamalinib waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT irvingstephaniea waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT lewisned waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT natarajankarthik waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT stenehjemedward waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT grannisshaunj waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT hanjungmi waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT mcevoycharlene waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT ongtoanc waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT nalewayallisonl waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT reesesarahe waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT embipeterj waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT dascombkristin waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT kleinnicolap waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT griggsericp waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT konathamdeepika waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT kharbandaanupamb waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT yangduckhye waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT fadelwilliamf waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT griselnancy waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT goddardkristin waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT patelpalak waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT liaoichia waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT birchrebecca waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT valvinimishr waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT reynoldssue waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT arndorferjulie waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT zerboousseny waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT dickersonmonica waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT murthykempapura waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT williamsjeremiah waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT boziocatherineh waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT blantonlenee waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT veranijenniferr waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT schragstephaniej waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT daltonalexandraf waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT wondimumehireth waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT linkgellesruth waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT azzizbaumgartnereduardo waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT barronmichellea waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT gaglanimanjusha waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT thompsonmarkg waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 AT firemanbruce waning2doseand3doseeffectivenessofmrnavaccinesagainstcovid19associatedemergencydepartmentandurgentcareencountersandhospitalizationsamongadultsduringperiodsofdeltaandomicronvariantpredominancevisionnetwork10statesaugust2021january2022 |